Compositions comprising the biologically active peptide YSL

Details Compositions comprising the biologically active peptide YSL Compositions comprising the biologically active peptide YSL

2002-09-05

2009-02-17

Szperka, Michael (Department: 1644)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S331000, C424S185100

Reexamination Certificate

active

07491689

ABSTRACT:
Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.

REFERENCES:
patent: 3992364 (1976-11-01), Kuhlmey
patent: 5504190 (1996-04-01), Houghten et al.
patent: 5529908 (1996-06-01), Palva et al.
patent: 5760000 (1998-06-01), Habibi
patent: 5861483 (1999-01-01), Wolpe
patent: 5874405 (1999-02-01), Birnbaum et al.
patent: 5932224 (1999-08-01), Chisari
patent: 5968514 (1999-10-01), Johnson et al.
patent: 6036952 (2000-03-01), Oh
patent: 6207456 (2001-03-01), Baru et al.
patent: 6245427 (2001-06-01), Düzgünes et al.
patent: 6268169 (2001-07-01), Fahnestock
patent: 6391585 (2002-05-01), Jang et al.
patent: 41 22 585 (1993-01-01), None
patent: 197 00 535 (1998-07-01), None
patent: 0257406 (1988-03-01), None
patent: 0 389 583 (1989-08-01), None
patent: 0382012 (1990-08-01), None
patent: 1142571 (1969-02-01), None
patent: WO 90/01326 (1990-02-01), None
patent: WO 95/35389 (1995-12-01), None
patent: WO 97/35602 (1997-10-01), None
patent: WO 98/12219 (1998-03-01), None
patent: 9859071 (1998-12-01), None
patent: WO 99/00418 (1999-01-01), None
patent: 0012762 (2000-03-01), None
patent: WO 00/63233 (2000-10-01), None
patent: 0129228 (2001-04-01), None
patent: WO 03/006492 (2003-01-01), None
patent: WO 03/006492 (2003-12-01), None
Whisstock et al., “Prediction of protein function from protein sequence and structure,” Quarterly Reviews of Biophysics, 2003, 36:307-340.
James et al., “Linear epitope mapping of an SM B/B′ Polypeptide,” Journal of Immunology, 1992, 148:2074-2079.
Furka et al., “String synthesis. A spatially addressable split procedure” (2000) J Comb Chem 2:220-223.
Owens et al., “Structure-activity relationship of the neurotransmitter alpha-bag cell peptide on Aplysia LUQ neurons: implications regarding its inactivation in the extracellular space” (1992) Journal of Neurobiology, 23:656-670.
The amino acid masses, downloaded Apr. 5, 2006 from haven.isb-sib.ch/tools/isotopident/htdocs/aa-list.html, one page.
Lai et al., J Pharm Sci, 1999, 88:489-500.
Ding et al., Bioorganic and Medicinal Chemistry, 2004, 12:4989-4994.
Furka et al. (2000) String synthesis. A spatially addressable split procedure. J. Comb. Chem. 2:220-223.
Owens et al. (1992) Structure-activity relationship of the neurotransmitter alpha-bag cell peptide onaplysiaLUQ neurons: implications regarding its inactivation in the extracellular space. Journal of Neurobiology. 23(6):656-670.
Squire et al. (1991) Leucine aminopeptidase-like activity inaplysiahemolymph rapidly degrades biologically active α-bag cell peptide fragments. The Journal of Biological Chemistry. 266(33):22355-22363.
Ngo et al. (1994) Computational complexity, protein structure prediction, and the levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction. p. 433 and 492-495.
Mikayama, et al. (1993) Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc.Natl.Acad.Sci. 90:10056-10060.
Sambrook et al. (1989) Molecular Cloning A Laboratory Manual, Second Edition. 17 Expression of Cloned Genes inEscherichia coli. CSH. 17.31-17.44.
Bulant, et al. 1990. Processing of thyrotropin-releasing hormone prohormone (pro-TRH) generates a biologically active peptide, prepro-TRH-(160-169), which regulates TRH-induced thyrotropin secretion.Proceedings of the National Academy of Sciences of the USA, 87(12):4439-4443.
Chang, et al. 1980. Isolation and structure of several peptides from porcine hypothalami.Biochimica et Biophysica Acta, 625:266-273.
Fogaca, et al. 1999. Antimicrobial activity of a bovine hemoglobin fragment in the tickBoophilus microplus. The Journal of Biological Chemistry, 274(36):25330-25334.
Karelin, et al. 1995. Proteolytic degradation of hemoglobin in erythrocytes leads to biologically active peptides.Peptides, 16(4):693-697.
Karelin, et al. 1998. Proteolytic degradation of hemoglobin in erythrocytes yields biologically active peptides.Bioorganicheskaia Khimiia, 24(4):271-281. (Russian).
Ladram, et al. 1992. Characterization of receptors for thyrotropin-releasing hormone-potentiating peptide on rat anterior pituitary membranes.The Journal of Biological Chemistry, 267(36):25697-25702.
Schally, et al. 1978. Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro acth-releasing activity corresponding to residues 33-46 of the α-chain of porcine hemoglobin.Biochemical and Biophysical Research Communications, 82(2):582-588.
Chem. Abs. No. 138168-48-6 dated Jan. 3, 1992.
Moisan et al., Structural Requirements and Mechanism of the Pressor Activity of Leu-Val-Val-hemorphin-7, a Fragment of Hemoglobin β-chain in Rats, 1998, Peptides, 19(1):119-131.
Katoh et al., Mapping Myosin-Binding Sites on Actin Probed by Peptides That Inhibit Actomyosin Interaction, 1996, J. Biochem., 120:580-586.
Hastings et al., cDNA clone analysis of six co-regulated mRNAs encoding skeletal muscle contractile proteins, 1982, Proc. Natl. Acad. USA, 79:1553-1557.
Hietter et al., Isolation and structure of two novel 6-kDa dimeric peptides from thecorpora cardiacaof the insectLocusta migratoria, 1989, Eur. J. Biochem., 182:77-84.
Mezo et al., The Influence of the Side-Chain Sequence on the Structure-Activity Correlations of Immunomodulatory Branched Polypeptides. Synthesis and Conformational Analysis of New Model Polypeptides, 1989, Biopolymers, 28:1801-1826.
Westermann et al., Synthetic peptides identify the minimal substrate requirements of tubulin polyglutamylase in side chain elongation, 1999, FEBS Letters, 459:90-94.
Firtel et al., Unusual nucleotide sequences at the 5′ end of actin genes inDictyostelium discoideum, 1979, Proc. Natl. Acad. Sci. USA, 76(12):6206-6210.
Genbank AAF04121, ncbi.nlm.nih.gov/entrez/view.fcgi?db=protein&id=6118500.

Affiliated with

Also associated with

Rating

Compositions comprising the biologically active peptide YSL does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions comprising the biologically active peptide YSL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising the biologically active peptide YSL will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4079389